C. Richard Reese's most recent trade in Charles River Laboratories International Inc. was a trade of 1,669 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 1,669 | 1,669 | - | - | Stock Options (Right to Buy) | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 664 | 65,099 (0%) | 0% | 0 | Common Stock | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 442 | 65,541 (0%) | 0% | 0 | Common Stock | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 1,582 | 1,582 | - | - | Stock Options (Right to Buy) | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 575 | 64,053 (0%) | 0% | 0 | Common Stock | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 382 | 64,435 (0%) | 0% | 0 | Common Stock | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,151 | 1,151 | - | - | Stock Options (Right to Buy) | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 355 | 63,244 (0%) | 0% | 0 | Common Stock | |
Charles River Laboratories... | C. Richard Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 234 | 63,478 (0%) | 0% | 0 | Common Stock |